Ka'idodin Opioid a cikin kwayar cutar ta farko da ke tsakiya ta hanyar watsa labaran cin abinci (2013)

Addict Biol. 24 ga Janairu, 2013. doi: 10.1111/adb.12033.

Blasio A , Steardo L , Sabino V , Cottone P.

source

Dakin gwaje-gwaje na Cututtukan Jaraba , Sashen Magunguna da Ilimin Halayyar Dan Adam, Makarantar Magunguna ta Jami'ar Boston, Boston, MA, Amurka.

Abstract

Rashin cin abinci mai yawa cuta ce da ke kama da jaraba wadda ke haifar da yawan cin abinci a cikin lokaci daban-daban.

Wannan binciken shine nufin fahimtar muhimmancin tsarin tsarin opioid a cikin kwayar jigilar magunguna (mPFC) a cikin abubuwan da suka dace da cin abinci irin na binge-like. A saboda wannan dalili, mun horar da 'yan ratsuka don samun kofin abinci, abincin da za a iya amfani da shi (Ratsan ratsi) ko rage cin abinci (Chow rats) don 1 awa / rana.

Daga nan muka kimanta tasirin mai karɓar opioid antagonist, naltrexone, wanda aka bayar ta hanyar tsari ko wuri-musamman a cikin ƙwayoyin nucleus (NAcc) ko mPFC akan madaidaicin rabo 1 (FR1) da jadawalin rabo mai ci gaba na ƙarfafa abinci.

A ƙarshe, mun yi nazarin maganganun kwayoyin proopiomelanocortin (POMC), pro-dynorphin (PDyn) da pro-enkephalin (PEnk), ƙayyadewa ga peptides na opioids a cikin NAcc da kuma mPFC a cikin bangarorin biyu.

Berayen da ake iya rage cin abinci da sauri sun ƙara yawan abincin da suke ci da sauri sau huɗu. Naltrexone, lokacin da ake ba shi ta hanyar tsari da kuma cikin NAcc, ya rage FR1 yana amsawa ga abinci da kuma kwarin gwiwa don cin abinci a ƙarƙashin rabo mai ci gaba a cikin berayen Chow da Palatable; akasin haka, lokacin da aka ba shi cikin mPFC, tasirin ya kasance mai matuƙar zaɓi ga berayen da ke cin abinci mai yawa. Bugu da ƙari, mun sami ƙaruwa sau biyu a cikin POMC da raguwar kusan kashi 50% a cikin bayyanar kwayar halittar PDyn a cikin mPFC na berayen Palatable, idan aka kwatanta da berayen da ke sarrafawa; duk da haka, babu wani canji da aka lura a cikin NAcc.

Bayananmu sun nuna cewa tsarin opioid a cikin mPFC yana faruwa ne bayan samun abinci mai daɗi akai-akai , wanda zai iya zama sanadin ci gaba da cin abinci mai kama da binge.

Gabatarwa

Matsalar cin abinci mai yawa tana bayyana ta hanyar yawan cin abinci mai daɗi da rashin iya sarrafa shi a cikin ɗan gajeren lokaci ( ; ; ). Mutanen da ke fuskantar cin abinci mai yawa suna kwatanta shi a matsayin rashin iko yayin cin abinci mai yawa, wanda ke haifar da cikar da ba ta da daɗi da kuma jin kunya mai tsanani ( ). Matsalar cin abinci mai yawa sau da yawa tana faruwa ne a cikin cututtuka da dama kamar kiba, ciwon suga, cututtukan zuciya da jijiyoyin jini, da kuma sauran cututtukan tabin hankali ( ; ).

An yi ƙoƙari sosai wajen ƙoƙarin gano abubuwan da ke taimakawa wajen haɓaka cin abinci mai yawa ( ; ). Wani ra'ayi da aka yarda da shi sosai game da asalin cin abinci mai yawa ya dogara ne akan canjin inganci na cin abinci mai daɗi. Hakika, ƙuntatawa ga abinci mai ƙarancin daɗi, "amintacce", wanda galibi ana haifar da shi ta hanyar al'adun da aka saba gani don siriri ko lafiya, na iya haifar da sha'awar abinci mai daɗi da yawa kuma yana haɓaka yawan cin abinci. Saboda haka, canjin tsari a cikin sauƙin sha'awa yana haifar da da'irar cin abinci mai cike da damuwa da kuma ƙuntatawa ( ; ), yana tayar da tambayar ko za a iya ɗaukar matsalar cin abinci mai cike da sha'awa a matsayin cuta mai kama da jaraba ( ; ; ; ).

Babu ingantattun magungunan rage cin abinci da ake da su a halin yanzu, kodayake an gabatar da manufofi daban-daban na gwaji ( ; ). An yi la'akari da tsarin opioid a matsayin ɗaya daga cikin manyan manufofin magance matsalolin cin abinci tun daga shekarun 1970, saboda lura da farko cewa masu adawa da opioid kamar naltrexone da naloxone sun sami damar rage yawan cin abinci ( ). Shaidu daga baya sun nuna cewa tsarin opioid yana da hannu a cikin daidaita halayen ciyarwa ta hanyoyi biyu, idan aka yi la'akari da ikon morphine na ƙara sha'awa a cikin berayen da ba su da abinci da waɗanda ba su da abinci ( ). Tun bayan waɗannan abubuwan da aka lura da farko, an fayyace wani muhimmin rawar da tsarin opioid ke takawa wajen daidaita abincin kuma shaidu masu yawa sun nuna cewa nucleus accumbens (NAcc) yana wakiltar wani muhimmin yanki da ke daidaita waɗannan tasirin ( ). Binciken da aka yi kwanan nan ya nuna cewa tsarin opioid na cin abinci mai gina jiki a cikin NAcc wani ɓangare ne na hanyar sadarwa mai rikitarwa, wanda ya ƙunshi tsarin kwakwalwa da yawa ciki har da yankunan prefronto-cortical ( ).

Kodayake babban layin bincike yana nuna mahimmancin mahimmancin tsarin opioid a cikin daidaituwa na palatability da ciyarwar hedonic, takamaiman yanki na kwakwalwa wanda tsarin opioid wanda ke tsoma baki game da cin abinci kamar-har yanzu ba a sani ba.

Saboda haka, manufar wannan binciken ita ce a tantance ko maganin opioid antagonist naltrexone, wanda aka ba shi ta hanyar tsari, ya sami damar rage cin abinci da kuma kwarin gwiwar samun abinci mai daɗi a cikin tsarin cin abinci mai kama da na beraye. Don wannan dalili, mun yi amfani da sabon tsarin aiki inda beraye ke ba da abinci mai daɗi da sukari da kansu a ƙarƙashin ƙarancin damar shiga (awa 1 a rana), suna kwaikwayon abubuwan da ke haifar da ci da ƙarfafawa da aka lura a cikin matsalar cin abinci mai yawa ( ). Daga nan muka ci gaba da tantance wane yanki na kwakwalwa ne ke da alhakin tasirin tsarin naltrexone wajen rage cin abinci da kuma kwarin gwiwar samun abinci mai daɗi da daɗi. Don wannan dalili, mun sanya wurin musamman opioid antagonist a cikin harsashin NAcc da mPFC. A ƙarshe, mun kimanta bayyanar kwayoyin halittar preOpioMelanoCortin (POMC), Pro-Dynorphin (PDyn), da Pro-Enkephalin (PEnk), muna ƙirƙirar peptides na opioid a cikin NAcc da mPFC bayan tarihin cin abinci mai kama da binge.

Abubuwa da hanyoyi

batutuwa

Berayen Wistar maza ( n = 70), 'yan kwanaki 41–47 bayan isowa (Charles River, Wilmington, MA) an ajiye su a cikin kejin filastik na yau da kullun da aka rufe da waya a cikin zagayowar haske na awanni 12:12 (fitilun kashewa a awanni 10:00), a cikin yanayin zafi (60%) da yanayin zafi (22 °C). Da isowa, beraye suna da damar samun abincin masara (Harlan Teklad LM-485 Diet 7012 (65% (kcal) carbohydrate, 13% mai, 21% furotin, 341 cal/100 g); Harlan, Indianapolis, IN) da kuma ruwa ad libitum a kowane lokaci. An bi ka'idojin da aka shimfida a cikin Jagorar Cibiyar Lafiya ta Ƙasa don Kulawa da Amfani da Dabbobin Dakunan Gwaji (NIH mai lamba 85-23, an sake duba ta 1996) da kuma Ka'idojin Kula da Dabbobin Dakunan Gwaji ( http://www.nap.edu/readingroom/bookslabrats ), kuma Kwamitin Kula da Dabbobin da Jami'ar Boston (IACUC) ya amince da su. Tsarin gwajin bai ƙunshi ƙuntatawa/rashin abinci ko ruwa ba, sai dai idan an ƙayyade akasin haka.

kwayoyi

An sayi Naltrexone, (5α)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydromorphinan-6-one hydrochloride, daga Abcam (Cambridge, MA). An narkar da Naltrexone sabo a cikin ruwan gishiri mai tace isotonic (0.9%) a ranar gwajin. An ba da Naltrexone ta hanyar subcutaneous (0, 0.03, 0.1 da 0.3 mg/kg, 1 ml/kg) mintuna 30 kafin zaman kuma an sanya shi - musamman a cikin harsashin NAcc da mPFC (0, 5 da 25 ug/gefe, na biyu) nan da nan kafin zaman. Allurai da lokutan kafin magani sun dogara ne akan wallafe-wallafen ( ; ; ).

Operant na binge-kamar cin abinci

An horar da waɗanda abin ya shafa don su ba da abinci da ruwa da kansu a cikin ɗakunan gwaji na masu aiki daban-daban da aka bayyana dalla-dalla a cikin ( ; ). Don ƙarin bayani, duba Ƙarin Kayayyaki da Hanyoyi.

Training

An yi amfani da tsarin cin abinci mai kama da binge kamar yadda aka bayyana a baya ( ). An ciyar da Beraye ( n = 70) abincin Harlan Teklad na yau da kullun a cikin kejin gidansu. Bayan wani lokaci na daidaitawa, an maye gurbin abinci da abinci mai tushen AIN-76A, wanda daga baya ake kira 'Chow A/I' (abincin 5TUM wanda aka tsara azaman ƙwai 4-5 da aka fitar, carbohydrate 65.5% (kcal), mai 10.4%, furotin 24.1%, kalori 330/100 g; TestDiet, Richmond, IN). An horar da Beraye don samun sarrafa kansu don abinci (ƙwai 45-mg daidai (Chow A/I)) da ruwa (100 µl) a ƙarƙashin jadawalin ƙarfafawa 1 ( ). Mai rarrabawa ya kawo kwalin daidai na 45-mg wanda yayi daidai da abincin da aka fitar daga kejin gida ~5g, domin tabbatar da cewa abincin berayen Chow ya dogara ne kawai da buƙatun homeostatic ( ; ). An yi zaman yau da kullun kafin zagayowar duhu ta fara kuma sun kasance awanni 1 a cikin lokaci.

Testing

Bayan an gudanar da gwajin a cikin zaman gudanarwa na sa'o'i 1, an fara gwajin. Beraye, waɗanda aka daidaita da nauyin jiki, abincin yau da kullun, ingancin abinci, da kuma amsawar ruwa da abinci a lokacin gudanar da kansu, an sanya su ga ko dai ƙungiyar kula da " Chow ", wacce a cikin akwatunan aiki ta karɓi ƙwallayen chow guda 45-mg da aka bayar a lokacin horo, ko kuma ƙungiyar " Palatable ", wacce a maimakon haka ta sami abinci mai gina jiki mai cikakken dandanon cakulan, mai yawan sucrose (50% kcal) na AIN-76A, wanda aka yi daidai da abun da ke cikin macronutrient da yawan kuzari ga abincin chow (Formula 5TUL mai ɗanɗanon cakulan: 66.7% [kcal] carbohydrate, 12.7% mai, 20.6% furotin, kuzarin da za a iya narkewa 344 cal/100g; an tsara shi azaman ƙwallayen abinci masu daidaito 45 mg; TestDiet, Richmond, IN). Duk beraye sun fi son wannan abincin da ke da ɗanɗanon cakulan ( , ). Ana gudanar da zaman kowace rana.

Jadawalin rabo jadawalin ƙarfafa abinci

Bayan daidaita shan abinci a cikin tsarin cin abinci mai kama da binge, an horar da beraye ( n = 53) a cikin rabo mai ci gaba ga masu ƙarfafa abinci (ƙwai 45-mg na chow-precise ga ƙungiyar Chow da 45-mg na cakulan, babban sucrose-precise pellet ga ƙungiyar Palatable ). An gudanar da jadawalin rabo mai ci gaba na ƙarfafa abinci kamar yadda aka bayyana a baya ( ; ; ). Don ƙarin bayani, duba Ƙarin Kayan Aiki da Hanyoyi . A ƙarshen kowane zaman, an mayar da mutane zuwa kejin gidansu inda Chow A/I koyaushe yana samuwa ad libitum ; ana gudanar da zaman kowace rana.

Gerarin aikin tiyata da hanyoyin microinfusion

Yin aikin tiyata

Bayan daidaita shan magani a lokacin da ake gudanar da aikin, an dasa beraye da cannulas na ciki. An yi tiyatar stereotaxic kamar yadda aka bayyana a baya ( ; ; ). Don ƙarin bayani, duba Kayayyaki da Hanyoyi na Ƙarin . Daidaitowar cannula da aka yi amfani da ita don harsashin NAcc da mPFC sune A/P +1.06 mm, M/L ± 0.75 mm, D/V −6.0 mm da A/P +3.2 mm, M/L ±0.65 mm, D/V −3.5 mm, bi da bi. An saita sandar interaural a kan ƙoƙon kai mai faɗi (dorsal/ventral: bregma = lambda); an tsara daidaitawar ne bisa ga atlas na Paxinos & Watson ( ). Salon bakin ƙarfe mai kama da bakin ƙarfe (Plastics One, Inc., Roanoke, VA, Amurka) yana da ikon sarrafawa. Bayan tiyata, an bar beraye su murmure daga tiyatar na tsawon mako 1 kafin a fara gwajin.

Tsarin microinfusion

Don ƙara yawan sinadarin naltrexone, an cire salon da ba a so daga cannula na jagora kuma an maye gurbinsa da allurar bakin ƙarfe mai girman 1.0 mm don harsashin NAcc da 1.5 mm don mPFC fiye da ƙarshen cannula na jagora; an haɗa allurar ta hanyar bututun PE 20 zuwa ga microsyringe na Hamilton wanda famfon microinfusion ke jagoranta (Kd Scientifics/Biological Instruments, Holliston, MA, Amurka). Microinfusions sun isar da ƙarar 0.5 µl a cikin mintuna 2; an bar allurar a wurin na ƙarin minti don rage yawan dawowa. An ba da jiyya a cikin cikakkun ƙira na murabba'in Latin, tare da kwanaki 1-3 na gwaji ba tare da magani ba, inda abincin da ake ci ya koma matakin farko. An ba beraye kwana 3 na daidaitawa da allurar sham na yau da kullun, kafin fara maganin magunguna. An tabbatar da sanya cannula ( Hoto na 4 ) a ƙarshen duk gwaji ta hanyar ƙara yawan sinadarin infusing na Indiya (0.5 µl a cikin mintuna 2). An tattara yanka na 40 µm ta amfani da na'urar cryostat kuma an tabbatar da wurin da aka sanya a ƙarƙashin na'urar hangen nesa. Daga cikin beraye 68 da aka yi amfani da su don nazarin microinfusion, an cire 3 saboda dalilai na tsari, waɗanda suka haɗa da asarar ko rufewar cannulae, ko rashin iya kiyaye aiki mai kyau. A cikin beraye 14 daga cikin sauran 65, matsayin cannula yana wajen wurin da aka nufa.

Figure 4 

Zane na kwakwalwar berayen. Dige tana wakiltar wuraren allurar cikin (A) NAcc harsashi da (B) an haɗa mPFC a cikin binciken bayanai.

Real-lokaci PCR

An yi amfani da ƙungiya ɗaya ta berayen Chow da Palatable ( n = 15) don auna peptides na POMC, PDyn, da PEnk mRNA. An yanka dabbobi awanni 24 bayan cin abinci na ƙarshe na yau da kullun kamar binge. Naushin tsakiya na prefrontal cortex ya haɗa da yankunan prelimbic da infralimbic. Naushin nucleus accumbens ya haɗa da yankuna na harsashi da tsakiya. An gudanar da hanyoyin kamar yadda aka bayyana a baya ( ). Don cikakkun bayanai, duba Ƙarin Kayan aiki da Hanyoyi.

ilimin kididdiga Analysis

An yi nazarin tasirin naltrexone akan cin abinci, shan ruwa, da kuma wurin da za a iya samun matsala ta amfani da ANOVAs masu tsari iri biyu, tare da Tarihin Abinci a matsayin abin da ke tsakanin mutane da kuma Jiyya a matsayin abin da ke cikin mutum, sannan aka maimaita matakan ANOVAs guda ɗaya. An yi nazarin tasirin Tarihin Abinci akan matakan mRNA ta amfani da gwaje-gwajen t- dalibai marasa haɗin kai . An yi nazarin canje-canjen da suka faɗi gwajin daidaito kamar yadda aka tsara ( ). Fakitin ƙididdiga da aka yi amfani da su sune Instat 3.0 (GraphPad, San Diego, CA) da Systat 11.0 (SPSS, Chicago, IL).

results

Sakamakon tsarin gudanarwa na opioid antagonist naltrexone akan cin abinci mai cin abinci kamar-cin abinci

Gudanar da tsari na kashi-kashi na naltrexone-a rage dogara da FR1 yana amsa abinci a duka Chow da kuma Palatable rukunoni (Hoto 1A; Jiyya: F(3,54) = 25.00, p<0.001; Tarihin Abinci X Jiyya: F(3,54) = 0.64, ns) Hanya guda daya ANOVAs ya tabbatar da tasirin magani a duka biyun Chow (Jiyya: F(3,27) = 7.62, p<0.0008) kuma Palatable beraye (Jiyya: F(3,27) = 16.78 p<0.0001). Bayanan bayanan bayanan sun nuna cewa, yayin da kashi 0.03 mg / kg basu da tasiri, duka magungunan 0.1 da 0.3 mg / kg sun rage ragamar sarrafa abinci a cikin ƙungiyoyin biyu, idan aka kwatanta da yanayin abin hawa. Bugu da ƙari, shan magani ya shafi tasirin magani (Table 1; Jiyya: F(3,54) = 8.46, p<0.0001; Tarihin Abinci X Jiyya: F(3,54) = 0.76, ns). Hanya guda daya ANOVAs ya tabbatar da tasirin magani a duka biyun Chow (Jiyya: F(3,27) = 4.97, p<0.007) kuma Palatable (Jiyya: F(3,27) = 3.76, p<0.022) beraye Bayanan bayanan bayanan sun nuna raguwar shan ruwa sosai bayan gudanar da allurai 0.1 da 0.3 mg / kg a cikin Chow berayen da sigar 0.3 mg / kg a Palatable berayen, idan aka kwatanta da yanayin abin hawa.

Figure 1 

Sakamakon jiyya na tsarin tare da naltrexone (0, 0.03, 0.1, 0.3 mg / kg, subcutaneously) on (A) sarrafa kai abinci (n= 20) da (B) Hali a kan tsarin rabo mai gudana na karfafawa (n= 19) a cikin ratsin Wistar na maza. Bangarori suna wakilta MSEM. ...
Table 1 

Sakamakon tsarin naltrexone akan ciwan ruwa

Sakamakon tsarin gudanarwa na opioid antagonist naltrexone a kan jadawalin rabo jadawalin ƙarfafa abinci

Naltrexone, wanda aka ba shi ta hanyar tsari, ya rage raunin da ya faru a cikin berayen Chow da Palatable ( Hoto na 1B ; Magani: F (3,51)=41.31, p <0.0001; Tarihin Abinci X Magani: F (3,51)=1.96, ns ). Bayan babban tasirin magani ( ƙungiyar Chow ; Magani: F (3,27)=5.99, p <0.003; Ƙungiya mai narkewa ; Magani: F (3,24)=6.87, p <0.002), binciken bayan hoc ya nuna cewa maganin 0.3 mg/kg ya rage raguwar raguwar a cikin ƙungiyoyin biyu sosai.

Sakamakon microinfusion naltrexone a cikin kwandon NAcc a kan cin abinci mai kama da cin abinci

Naltrexone microinfusion cikin NAcc kashi-dogara rage martani don abinci a duka biyu Chow da kuma Palatable ƙungiyar (Hoto 2A; Jiyya: F(2,32) = 10.76, p<0.0001; Tarihin Abinci X Jiyya: F(2,32) = 4.36, p<0.02). Hanya guda ANOVAs ta bayyana tasirin magani a cikin duka biyun Chow (Jiyya: F(2,18) = 5.72, p<0.01) kuma Palatable beraye (Jiyya: F(2,18) = 5.344, p<0.02) daidai da haka. Bugu da ƙari kuma, nazarin bayanan bayan fage ya bayyana raguwa mai yawa a cikin tsarin kula da abinci bayan shan magani tare da mafi girman kashi (25 µg) a duka biyun Chow da kuma Palatable kungiyoyi. Rashin maganin bai shafi aikin magani ba (kawai)Table 1; Jiyya: F(2,32) = 2.48, ns; Tarihin Abincin X: F(2,32) = 0.65, ns).

Figure 2 

Tasiri na microinfusion tare da naltrexone (0, 5, 25 µg / side) a cikin kwalliyar NAcc (A) sarrafa kai abinci (n= 18) da (B) Hali a kan tsarin rabo mai gudana na karfafawa (n= 17) a cikin ratsin Wistar na maza. Panel wakilci MSEM. Alamu ...

Tasirin microinfusion na naltrexone a cikin kwarin NAcc akan jadawalin rabo na ci gaba na abinci

Lokacin da naltrexone aka kasance shafin-musamman microinfused a cikin NAcc, babban mahimmanci rage yawan fashewar a duka Chow da kuma Palatable An lura da rukunin (Hoto na 2B; Jiyya: F(2,30) = 16.72, p<0.0001; Tarihin Abinci X Jiyya: F(2,30) = 5.22, p<0.01). An tabbatar da wannan sakamakon ta hanya guda ANOVAs da ake aiwatarwa daban-daban akan kowane rukuni biyu (Chow rukuni; Jiyya: F(2,16) = 6.11, p<0.01; Palatable rukuni; Jiyya: F(2,14) = 10.62, p<0.001). Binciken bayan-lokaci ya nuna raguwa mai yawa a cikin ƙungiyoyin biyu lokacin da aka ƙaddamar da ƙwayoyin 5 da 25 µg. Rage fashewar ya kasance kwatankwacin girma tsakanin Chow da kuma Palatable berayen (50.8% da 53.2%, idan aka kwatanta da yanayin abin hawa, bi da bi).

Sakamakon microinfusion naltrexone a cikin MPFC akan cin abinci mai cin abinci kamar cin abinci

Naltrexone shafin-musamman microinfused a cikin mPFC bambancin abin da abinci ya shafa yana amsawa a ciki Chow da kuma Palatable berayen, kamar yadda muka bayyana ta muhimmiyar ma'amala (Hoto 3A; Jiyya: F(2,30) = 4.77, p<0.02; Tarihin Abinci X Jiyya: F(2,30) = 5.08, p<0.01). Tabbas, yayin da naltrexone bai tasiri amsawa ga chow ba Chow beraye (Jiyya: F(2,12) = 0.68, ns), shi kashi-dogara rage binge-kamar cin a Palatable beraye (Jiyya: F(2,18) = 9.25, p<0.002), tare da bayanan bayanan da ke nuna raguwa mai yawa bayan bin 25 µg kashi, idan aka kwatanta da yanayin abin hawa. Sabili da haka, naltrexone, microinfused a cikin mPFC, abin da aka zaɓa kamar binge kamar cin abinci a ciki Palatable berayen, ba tare da haifar da ciyarwa a cikin berayen sarrafawa ba. Bugu da kari, naltrexone bashi da wani tasiri game da shan ruwa (Table 1; Jiyya: F(2,30) = 1.89, ns; Tarihin Abincin X: F(2,30) = 0.69, ns).

Figure 3 

Tasiri na microinfusion tare da naltrexone (0, 5, 25 µg / gefe) a cikin mPFC a kan (A) sarrafa kai abinci (n= 17) da (B) kwance a kan jadawalin rabo jadawalin karfafawa (n= 17) a cikin ratsin Wistar na maza. Panel wakilci MSEM. Alamu suna nuna: ...

Sakamakon microinfusion naltrexone a cikin mPFC akan jadawalin rabo na ci gaba na abinci don abinci

An yi wani ANOVA mai hanyoyi biyu a kan hanyar da beraye Chow da Palatable suka karye bayan microinfusion na naltrexone cikin mPFC ya bayyana babban tasirin maganin magani ( Hoto na 3B ; Magani: F (2,30)=9.057, p <0.001; Tarihin Abinci X Jiyya: F(2,30)=1.84, ns ). Duk da haka, kodayake binciken ANOVA mai hanya ɗaya ya bayyana tasirin maganin magani a cikin ƙungiyar Chow (Magani: F (2,18)=4.43, p <0.027), bayan binciken bayan hoc, babu 5 µg ko 25 µg da ya bambanta sosai da yanayin abin hawa. Wataƙila, tasirin maganin da ANOVA ya nuna ya samo asali ne daga yanayin da ke zuwa ga ƙaruwar lokacin da aka karya bayan 5 µg na maganin, idan aka kwatanta da yanayin abin hawa. A gefe guda kuma, a cikin ƙungiyar Palatable , ana iya ganin babban tasirin maganin miyagun ƙwayoyi (Magani: F (2,12)=5.31, p <0.02), kuma mafi girman allurar da aka saka a cikin mPFC ta rage yawan karyewar, idan aka kwatanta da yanayin abin hawa.

Real-lokaci PCR

PCR na ainihin lokaci ya nuna cewa, awanni 24 bayan zaman cin abinci na ƙarshe, babu wani bambanci mai mahimmanci a cikin bayyanar POMC, PDyn, da PEnk tsakanin berayen Chow da Palatable a cikin NAcc ( Figures 5A, 5B, da 5C ). Duk da haka, matakan POMC mRNA sun fi girma sosai a cikin PFC na berayen Palatable , idan aka kwatanta da berayen Chow (ƙarin 117.9%; Hoto na 5D ). Bugu da ƙari, matakan bayyanar PDyn a cikin PFC na berayen Palatable sun yi ƙasa sosai idan aka kwatanta da berayen Chow (rage 49.3%; Hoto na 5E ). Babu wani bambanci tsakanin ƙungiyoyin biyu da aka lura a cikin matakan PEnk mRNA a cikin PFC ( Hoto na 5F ).

Figure 5 

POMC, PDyn, da PEnk mRNA magana a cikin NAcc (A, B da kuma C) kuma a cikin mPFC (D, E da kuma F) na berayen Wistar. An tattara wuraren kwakwalwan 24 h bayan kammala taron cin abinci na yau da kullun na ƙarshe. Data wakilta MSEM aka bayyana a matsayin kashi na Chow rukuni; ...

tattaunawa

A cikin wannan binciken mun nuna cewa opioid antagonist naltrexone, ana sarrafa shi ta hanyar tsari, ba musamman rage yawan amfani da dalili don samun abinci ba, kazalika da rage yawan shan ruwa a cikin berayen biyu masu sarrafa kansu ta cinye abinci da berayen da ke birgima a kan sosai rage cin abinci abincin. Mahimmanci, yayin da tasirin ciwan chow da abincin abinci mai mahimmanci a yayin da aka kula da naltrexone a cikin kwandon na NAcc, opioid antagonist ya zaɓi rage amfani da motsawa don samun abinci mai ƙima sosai, amma ba kwaya ta yau da kullun ba, lokacin da microinfused ya shiga cikin mPFC. Bugu da ƙari, tabbatar da zaɓin sakamakon tasirin halayen da aka lura da su biyo bayan microinfusion na naltrexone a cikin mPFC, mRNA na POMC da PDyn an dysregulated a cikin mPFC, amma ba a cikin NAcc ba, na cin abinci bera a kwatanta don sarrafa berayen. Babu wani sakamako da aka lura da shi a cikin bayanin halittar PEnk a kowane yanki.

Saboda haka, shan naltrexone ta hanyar tsari ya rage yawan cin abinci na berayen Palatable da Chow ta hanyar amfani da kashi . Maganin magunguna na tsari ya kuma rage kwarin gwiwar yin aiki, domin samun abinci mai daɗi da kuma abinci mai daɗi a cikin jadawalin ƙarfafawa mai ci gaba, wani tsari na ɗabi'a da aka tabbatar da aka yi amfani da shi don tantance ƙarfin ƙarfafawa don samun masu ƙarfafawa ( ; ). Bayan shan naltrexone mafi girman allurai a ƙarƙashin fata, girman tasirin da ya fi yawa a cikin rage amsawar FR1 da kuma raguwar jadawalin ƙarfafawa mai ci gaba ya kasance iri ɗaya a cikin ƙungiyoyi biyu (FR1: 58.2% da 54.0%; rabon ci gaba: 40.5% da 43.3%, idan aka kwatanta da yanayin abin hawa a cikin berayen Chow da Palatable , bi da bi). Saboda haka, tasirin naltrexone na tsarin abinci mai yiwuwa ya haɗa da rage halayyar ciyar da abinci ta homeostatic da hedonic ( ). Abin sha'awa, tasirin shan naltrexone na ƙarƙashin ƙasa ba zaɓi bane ga abinci, tunda maganin ƙwayoyi ya rage shan ruwa a cikin sarrafawa da cin berayen da ke cin abinci mai yawa. Gabaɗaya, waɗannan abubuwan da aka lura da farko suna nuna tasirin dannewa gabaɗaya akan halayen cin abinci, bayan shan magani tare da opioid antagonist ( ).

A cikin wannan binciken mun so mu tantance ko masu karɓar opioid a cikin harsashin NAcc sun jagoranci ɓangarorin cin abinci masu kama da binge-like. Hakika, an gabatar da tsarin opioid a wannan yanki don shiga cikin daidaita halayen abinci masu lada ( ). A nan mun nuna cewa naltrexone microinfused a cikin harsashin NAcc ba kawai ya rage cin abinci mai kama da binge-like na abinci mai daɗi ba, har ma da cin abinci na yau da kullun. An sami irin wannan sakamako lokacin da muka gwada tasirin naltrexone microinfusion a cikin harsashin NAcc akan hanyar da aka yanke ta jadawalin rabo mai ci gaba na ƙarfafa abinci. Hakika, maganin miyagun ƙwayoyi ya rage sha'awar samun abinci a cikin cin abinci mai yawa da kuma sarrafa beraye. Waɗannan binciken sun nuna cewa masu karɓar opioid a cikin harsashin NAcc suna yin gyare-gyare gabaɗaya na halayyar ciyarwa da ƙarfafa ingancin abinci, ba tare da la'akari da nau'in ko daga tasirin abincin ba. Don tallafawa wannan hasashe, Kelley da abokan aikinsa sun nuna cewa toshewar masu karɓar μ-opioid a cikin NAcc yana rage yawan cin abinci na yau da kullun na chow da kuma maganin sucrose ( ). Sabanin abin da muka lura bayan shan naltrexone a cikin tsari, ƙwayar maganin NAcc ba ta shafi shan ruwa ba, yana nuna cewa masu karɓar opioid a cikin wannan yankin kwakwalwa suna da hannu musamman a cikin daidaita halayen ciyarwa, maimakon gabaɗaya a cikin halayen cin abinci, ko kuma ana buƙatar ƙarin allurai don hana shan ruwa.

Mun kuma bincika ko tsarin opioid a cikin mPFC yana da mahimmanci wajen daidaita cin abinci mai daɗi kamar binge-like. A cikin bincikenmu, microinfusion na mPFC na opioid antagonist zaɓi da kuma bisa ga kashi ya rage duka amfani da kuma kwarin gwiwa don samun abinci mai daɗi a cikin berayen da ke cin abinci mai yawa, ba tare da shafar shan giya akai-akai a cikin berayen da ke sarrafa abinci ba. Shan ruwa bai shafi shan ruwa a cikin kowane rukuni ba, yana nuna cewa tasirin yana da zaɓi don halayyar ciyarwa. An danganta yankunan gaba-gaba na kwakwalwa a cikin daidaita halayen ciyarwa ( ). Wani rahoto na baya-bayan nan ya kuma nuna cewa masu karɓar μ-opioid a cikin mPFC suna taka muhimmiyar rawa wajen haifar da yawan cin abinci mai yawa ( ).

Yana da mahimmanci a tattauna fassarar madadin cewa tasirin naltrexone na iya faruwa ne sakamakon saurin yaɗuwa a cikin kwakwalwa da kewaye, akasin haka ga sauran masu adawa da opiate na quaternary ( ; ) waɗanda ke da ƙarancin yaduwar cutar ( ). Sabanin wannan fassarar akwai shaidar cewa, a cikin wannan binciken, an haɗa naltrexone a cikin sassan kwakwalwa daban-daban guda biyu (NAcc da PFC) a cikin berayen Chow suna da tasirin bambanci. Bugu da ƙari, nazarin lokaci na amsawar abinci ya nuna cewa naltrexone da aka allura a cikin mPFC ya rage amsawar abinci a cikin berayen Palatable bayan mintuna 6 kacal bayan microinfusion ( M ±SEM: 84.3±7.5 vs. 75.3±6.6, veh vs. 25 µg/gefe, bi da bi, p <0.05). Saboda ɗan gajeren lokacin, fassarar madadin cewa tasirin da aka lura zai iya haifarwa ko dai daga toshewar CNS ko na gefe na masu karɓar opioid ba abu ne mai yiwuwa ba. Bugu da ƙari, don tallafawa ingancin bayanan da aka samu a cikin wannan binciken, wallafe-wallafe sun ba da rahoton tasirin naltrexone microinfused a takamaiman sassan kwakwalwa ( ). Duk da haka, ba za a iya cire hasashen cewa tasirin naltrexone na iya dogara da ɗan yaɗuwa a cikin sassan kwakwalwa da ke kusa da Nacc shell ko PFC ba.

Wata hanyar fassara rashin tasirin da ake samu a kan cin abinci bayan an yi amfani da naltrexone microinfusion a cikin prefrontal cortex na berayen Chow ita ce tasirin da aka lura na iya faruwa ne sakamakon toshewar masu karɓar mu da kappa opioid tare. Duk da cewa an nuna cewa tsarin biyu suna yin tasirin modulatory akasin haka a cikin matakai da yawa ciki har da lada, an nuna cewa suna daidaita ciyarwar homeostatic (kamar cin abinci a cikin dabbobin Chow na wannan binciken) ta hanya iri ɗaya. An nuna cewa kunna masu karɓar mu da kappa opioid yana ƙara yawan cin abinci, yayin da aka nuna cewa toshewar su yana haifar da tasirin rashin abinci ( ; ) Saboda haka, bincikenmu yana nuna bambanci a cikin daidaita halayen cin abinci da tsarin opioid ke gudanarwa a cikin NAcc da mPFC; yayin da masu karɓar NAcc opioid da alama suna da hannu a cikin tsarin daidaita abinci gabaɗaya, ba tare da la'akari da nau'in abincin da aka ci ba ( ), tsarin opioid na mPFC da alama ana ɗaukarsa ne kawai bayan tarihin ƙarancin damar cin abinci mai sukari da daɗi, lokacin da beraye suka rasa ikon hana abinci. Wannan hasashe ya yi daidai da babban aikin fahimta da kuma rikitarwa na kimanta lada da mPFC ke gudanarwa.

Tsarin asalin mafi yawan jama'a, ba matsayin takamaiman rawar da masu karɓa na NAcc ke karɓa ba a cikin yanayin sasantawa game da halayyar ciyarwa, da kuma zaɓi na MPFC wanda aka goyan bayan ƙididdigar magana ta POMC, PDyn, da PEnk. Babu wani bambanci mai mahimmanci a cikin bayanin kwayoyin halittar guda uku da aka gani a cikin NAcc, lokacin da aka kwatanta yawan cin abincin da sarrafa bera. Hakanan, a cikin mPFC, berayen cin abinci ya nuna ƙaruwa fiye da ninki biyu a cikin matakan POMC mRNA, tare da ragin ~ 50% raguwa a cikin matakan mRNA na PDyn, idan aka kwatanta da sarrafa berayen.

An nuna cewa kwayoyin halittar POMC da PDyn suna bayyana a cikin waɗannan sassan kwakwalwa guda biyu ( ; ; ). (Duk da haka, shaidu sun nuna cewa peptides na opioid da aka saki a cikin mPFC suma na iya fitowa daga jikin ƙwayoyin halitta da ke fitowa daga yankuna daban-daban na kwakwalwa (watau yankin ventral tegmental area ( )), wanda ke haifar da yuwuwar cewa tasirin da aka lura a cikin wannan binciken bayan microinfusion naltrexone a cikin mPFC na iya zama ba shi da alaƙa da bambancin bayyanar POMC da Pdyn a cikin wannan yankin kwakwalwa. POMC shine farkon endorphins waɗanda suka fi son ɗaure μ (amma kuma δ) masu karɓar opioid ( ), yayin da PDyn shine farkon dynorphins waɗanda suka fi son ɗaure masu karɓar κ-opioid ( ). Shaida mai yawa ta nuna rawar da masu karɓar μ- da κ-opioid ke takawa wajen daidaita ayyuka daban-daban a cikin kwakwalwa, gami da analgesia, haƙuri, hanyoyin ƙwaƙwalwa, da lada ( ; ). Musamman kuma daidai da wannan An tabbatar da cewa masu karɓar μ-opioid sun yi tasiri sosai wajen daidaita halayen abinci da wasu magunguna na cin zarafi ( ); a gefe guda kuma, an nuna cewa masu karɓar κ-opioid suna yin sulhu kan tasirinsu na rashin lada da rashin lada, kuma an gabatar da su a matsayin wani ɓangare na tsarin "anti-reward" ( ). Mafi mahimmanci, a cikin mahallin wannan binciken, an nuna cewa kunna magungunan ko dai masu karɓar μ- ko κ-opioid a cikin prefrontal cortex yana yin tasirin sakamako mai kyau: ƙananan infusions na mai karɓar μ-opioid mai zaɓi yana haifar da fifikon wuri, yayin da ƙananan infusions na mai karɓar κ-opioid yana haifar da ƙyamar wuri ( ).

Muhimmin batu na tattaunawa shi ne ko canje-canje a cikin yanayin mRNA da aka lura a cikin wannan binciken ya dogara ne akan bambance-bambancen da ke cikin yawan cin abinci mai kalori ko nauyin jiki tsakanin berayen Chow da Palatable . Duk da cewa ba a rubuta yawan cin abinci da nauyin jiki a cikin ƙungiyar dabbobin da aka yi amfani da su don PCR na Real-Time ba, mun nuna a baya cewa tsarin cin abinci mai kama da binge da aka yi amfani da shi a nan ba ya shafar yawan cin abinci mai yawa ko nauyin jiki. Hakika, berayen da ke cin abinci mai yawa suna nuna yawan cin abinci mai yawa a lokacin sa'o'i 1 na samun damar cin abinci mai daɗi, amma suna ramawa a cikin sauran sa'o'i 23 na rana ta hanyar rage cin abinci na yau da kullun ( ). Saboda haka, wannan yanayin cin abinci mara kyau ba ya haifar da bambancin yawan cin abinci mai kalori ko nauyin jiki tsakanin cin abinci mai yawa da kuma sarrafa berayen ( ).

Duk da cewa an gabatar da kamanceceniya tsakanin tsarin cin abinci mai yawa/ƙuntatawa a cikin matsalar cin abinci mai yawa da kuma tsarin maye/janyewar shan miyagun ƙwayoyi ( ), ko samfurin dabba da aka yi amfani da shi a cikin wannan binciken zai iya zama da amfani ga binciken, ba a san ko alamun rashin lafiyar da ke tattare da janyewa daga abincin mai daɗi ba ne. Ƙara yawan bayyanar POMC (“tsarin bayar da lada”) da raguwar bayyanar Pdyn (“tsarin hana lada”) da aka lura a nan bayan janyewa daga abincin mai daɗi na awanni 24 sun nuna cewa dabbobin ba sa fuskantar mummunan yanayin motsin rai. Duk da haka, don magance wannan muhimmin al'amari na zagayowar abinci, za a buƙaci ƙarin nazarin tantance motsin rai da yuwuwar shigar da tsarin damuwa (misali corticotropin-releasing factor). Saboda haka, canje-canje daban-daban a cikin bayyanar kwayar halittar POMC da Pdyn da aka lura a cikin mPFC za a iya fassara su a matsayin babban ƙarfin halayen abinci mai daɗi, wanda zai iya zama sakamakon ko haifar da cin abinci mai yawa a cikin waɗannan batutuwa.

Gabaɗaya, sakamakon wannan binciken ya goyi bayan hasashen cewa tsarin opioid a yankunan prefronto-cortical na kwakwalwa yana da hannu a cikin sarrafa halayen ciyarwa kuma yana faɗaɗa shi zuwa takamaiman mahallin rashin daidaituwa na yawan cin abinci mai daɗi da aka gani a cikin masu cin abinci mai yawa ( ). Yankunan fronto-cortical na kwakwalwa suna taka muhimmiyar rawa a cikin kimantawa da yanke shawara ( ); wallafe-wallafe masu yawa sun nuna cewa mutanen da ke fama da jaraba da rashin cin abinci mai yawa suna nuna rashin aiki a cikin mPFC, waɗanda ke da alaƙa da kimantawar lada da aka canza ( ). Saboda haka, lura da halayenmu, magunguna, da kwayoyin halitta, saboda haka, suna tallafawa hasashen cewa tsarin opioid babban mai shiga tsakani ne na ciyar da hedonic ( ) kuma suna ba da shawarar cewa daidaitawar neuro na tsarin opioid a cikin mPFC na iya zama alhakin ƙimar abinci mai daɗi sosai, wanda ke haifar da asarar iko akan cin abinci.

 

Karin kayan

Kayan aiki

Acknowledgments

Muna gode wa Stephen St. Cyr, Aditi R. Narayan, Vamsee Neerukonda, Noah Kelley, Jin Won Park, Anoop Ravilla, da Sishir Yeety don taimakon fasaha, da Tamara Zeric don taimakon edita. An buga wannan bugun ta hanyar lambobin bada tallafi DA023680, DA030425, MH091945, MH093650A1, da AA016731 ​​daga Cibiyar Nazarin Magunguna ta Kasa (NIDA), Cibiyar Kiwon Lafiyar Hauka ta Kasa (NIMH) da Cibiyar Kula da Shaye-shaye da Barasa (NIAAA) , ta Peter Paul Career Development Professorship (PC) da kuma na Kwalejin Ilimin Samun Karatun Karatun Digiri na biyu na Jami'ar Boston (UROP). Abubuwan da ke ciki kawai alhakin marubuta ne kuma ba lallai ba ne su wakilci ra'ayoyin hukuma na Cibiyoyin Kiwan Lafiya na .asa.

Bayanan kalmomi

Gudummawar marubuta

AB, PC da VS sun kasance masu alhakin manufar nazarin da ƙira. AB, PC, da VS sun gudanar da gwaje-gwajen halayyar da kwayoyin halitta. AB da PC sun gudanar da binciken bayanai. PC, VS da LS sun taimaka wajan fassarar binciken. AB da PC sun rubuta rubutun. PC, VS da LS sun ba da bita mai mahimmanci game da rubutun don mahimmancin abubuwan hankali. Duk marubutan sunyi zurfin nazarin abun ciki kuma an tabbatar da sigar karshe don bugawa.

 

References

  • Akritas MG. Hanyar canza wuri a wasu kayayyaki masu fasali guda biyu. Jaridar Statungiyar istididdiga ta Amurka. 1990; 85 (409): 73 – 78.
  • Avena NM, Rada P, Hoebel BG. Shaida don jarabar sukari: halayyar da tasirin neurochemical na rikitarwa, yawan shan sukari mai yawa. Neurosci Biobehav Rev. 2008; 32 (1): 20 – 39. [PMC free article] [PubMed]
  • Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS. Rukunan yanar gizo masu tsaka-tsakin yanayi wadanda ke yin sulhu kan tasirin opioids kamar yadda aka tsara matsayin fifikon yanayi a cikin beraye. J Pharmacol Exp Ther. 1993; 264 (1): 489 – 495. [PubMed]
  • Blasio A, Narayan AR, Kaminski BJ, Steardo L, Sabino V, Cottone P. An daidaita aikin gyara jinkiri don tantance zaɓin mai ƙarfi tsakanin rakodin isocaloric a cikin berayen marasa lalacewa: tasirin 5-HT (2) A / C da 5 -HT (1) Masu karɓar rayayyar masu karɓa. Psychopharmacology (Berl) 2012; 219 (2): 377 – 386. [PMC free article] [PubMed]
  • Bodnar RJ, Gilashin MJ, Ragnauth A, Cooper ML. Janar, mu da kappa opioid antagonists a cikin nucleus yana haɓaka haɗarin abinci a ƙarƙashin talauci, yanayin glucoprivic da yanayin rashin damuwa. Brain Res. 1995; 700 (1 – 2): 205 – 212. [PubMed]
  • Bodnar RJ, Lamonte N, Israel Y, Kandov Y, Ackerman TF, Khaimova E. Sakamakon rikice-rikicen opioid-opioid tsakanin yankin ventral tegmental yanki da kuma nucleus yana hana yankuna a cikin sasantawa don haifar da ciyarwar agonist. Peptides. 2005; 26 (4): 621 – 629. [PubMed]
  • Boeka AG, Lokken KL. Tsarin tsari na riga ya shiga cikin yawan cin abinci. Ku ci Rashin nauyi. 2011; 16 (2): e121 – e126. [PubMed]
  • Carlezon WA, Jr, Devine DP, Mai hikima RA. Matakan samar da abubuwa masu narkewar sinadarin nomifensine a cikin kwayar halittar hanji. Psychopharmacology (Berl) 1995; 122 (2): 194 – 197. [PubMed]
  • Clark L, Bechara A, Damasio H, Aitken MR, Sahakian BJ, Robbins TW. Sakamakon bambanci na bandeji da ventromedial prefrontal cortex raunuka akan yanke shawara mai haɗari. Kwakwalwa 2008; 131 (Pt 5): 1311 – 1322. [PMC free article] [PubMed]
  • Cooper SJ, Jackson A, Kirkham TC. Endorphins da abincin abinci: kappa opioid receptor agonists da hyperphagia. Pharmacol Biochem Behav. 1985; 23 (5): 889 – 901. [PubMed]
  • Corwin RL. Berayen bera: wani ƙabilanci ne na halayen wuce kima? Ci. 2006; 46 (1): 11 – 15. [PMC free article] [PubMed]
  • Corwin RL, Grigson PS. Bayanin Taro - –arashin abinci: gaskiya ko almara? J Nutr. 2009; 139 (3): 617-619. [PMC free article] [PubMed]
  • Cottone P, Sabino V, Nagy TR, Coscina DV, Zorrilla EP. Ciyar da ƙananan ƙwayoyin cuta a cikin abinci mai haifar da kiba mai saurin kamuwa da berayen da za'a iya jurewa: sakamakon tsakiya na urocortin 2. J Jiyan 2007; 583 (Pt 2): 487 – 504. [PMC free article] [PubMed]
  • Cottone P, Sabino V, Roberto M, Bajo M, Pockros L, Frihauf JB, Fekete EM, Steardo L, Rice KC, Grigoriadis DE, Conti B, Koob GF, Zorrilla EP. Samun tsarin CRF ya shiga tsakani wani yanki mai duhu na tilasta abinci. Proc Natl Acad Sci US A. 2009; 106 (47): 20016 – 20020. [PMC free article] [PubMed]
  • Cottone P, Sabino V, Steardo L, Zorrilla EP. Shigarwa ta wucin gadi ga abincin da aka fifita yana rage ingancin ɗanɗano a cikin beraye. Am J Physiol Regul Integr Comp Physiol. 2008a; 295 (4): R1066 – R1076. [PMC free article] [PubMed]
  • Cottone P, Sabino V, Steardo L, Zorrilla EP. Opioid mai dogaro mai banbanci na banbanci da binge-kamar cin abinci a beraye tare da iyakance dama ga abincin da aka fi so. Neuropsychopharmacology. 2008b; 33 (3): 524 – 535. [PubMed]
  • Cottone P, Wang X, Park JW, Valenza M, Blasio A, Kwak J, Iyer MR, Steardo L, Rice KC, Hayashi T, Sabino V. Antagonism na Sigma-1 Masu Karɓar Tubalan Takaddama-Kamar Cin abinci. Neuropsychopharmacology. 2012 [PMC free article] [PubMed]
  • Rana ta R, Lazure C, Basak A, Boudreault A, Limperis P, Dong W, Lindberg I. Prodynorphin sarrafawa ta hanyar juyawar 2. Cleavage a raguna na asali guda ɗaya da haɓaka aiki a gaban aikin carbonxypeptidase. J Biol Chem. 1998; 273 (2): 829 – 836. [PubMed]
  • Epstein DH, Shaham Y. Yankuna masu cin abinci na Cheesecake da kuma matsalar jarabawar abinci. Nat Neurosci. 2010; 13 (5): 529 – 531. [PMC free article] [PubMed]
  • Frenk H, Rogers GH. Tasirin kwayar naloxone akan abinci da shan ruwa a cikin bera. Behav Neural Biol. 1979; 26 (1): 23 – 40. [PubMed]
  • Garzon M, Pickel VM. Alizationididdigar ƙasa mai narkewa na Leu5-enkephalin immunoreactivity a cikin mesocortical neurons da ƙarshen shigarwar su a cikin yankin ventral tegmental rat. Synapse. 2004; 52 (1): 38 – 52. [PubMed]
  • Gosnell BA, Levine AS, Morley JE. Imuarfafa yawan ci abinci ta hanyar zaɓar agonists na mu, kappa da masu karɓa na opioid. Rayuwa Sci. 1986; 38 (12): 1081 – 1088. [PubMed]
  • Hagan MM, Moss DE. Istoƙarin tsarin cin abinci mai yawa bayan tarihin hanawa tare da adadin abubuwan da suka dace na yin magana akan abinci mai ban sha'awa a cikin beraye: abubuwan da ke haifar da bulimia nervosa. Int J Ku Rasa Damuwa. 1997; 22 (4): 411 – 420. [PubMed]
  • Holtzman SG. Halin tasirin halayen rarrabuwan kai da haɗuwa da naloxone da d-amphetamine. J Pharmacol Exp Ther. 1974; 189 (1): 51 – 60. [PubMed]
  • Iemolo A, Valenza M, Tozier L, Knapp CM, Kornetsky C, Steardo L, Sabino V, Cottone P. Rashin iska mai kazanta, rashin daidaituwa ga abinci mai tsananin gaske yana haifar da rashin damuwa kamar hali a cikin berayen cin abinci. Behav Pharmacol. 2012; 23 (5 – 6): 593 – 602. [PMC free article] [PubMed]
  • Javaras KN, Paparoma HG, Lalonde JK, Roberts JL, Nillni YI, Laird NM, Bulik CM, Crow SJ, McElroy SL, Walsh BT, Tsuang MT, Rosenthal NR, Hudson JI. Hadin gwiwa game da matsalar yawan cin abinci tare da cutar kwakwalwa da kuma rashin lafiya. J Clin ilimin tabin hankali. 2008; 69 (2): 266 – 273. [PubMed]
  • Kelley AE, Bless EP, Swanson CJ. Binciken tasirin magabatan opiate sun haifar cikin tarin kwayoyin halittu na ciyarwa da kuma maye gurbin shan giya. J Pharmacol Exp Ther. 1996; 278 (3): 1499 – 1507. [PubMed]
  • Koob GF, Le Moal M. Magungunan kwayoyi, dysregulation na lada, da allostasis. Neuropsychopharmacology. 2001; 24 (2): 97 – 129. [PubMed]
  • Laessle RG, Tuschl RJ, Kotthaus BC, Pirke KM. Halayyar halayen halitta da abubuwan da ke tattare da hana abubuwan da suka dace a rayuwa. Ci. 1989; 12 (2): 83 – 94. [PubMed]
  • Le Merrer J, Becker JA, Befort K, Kieffer BL. Gudanar da sakamako ta tsarin opioid a cikin kwakwalwa. Physiol Rev. 2009; 89 (4): 1379 – 1412. [PMC free article] [PubMed]
  • Leriche M, Cote-Velez A, Mendez M. gaban gaban pro-opiomelanocortin mRNA a cikin tsintsiyar medial prefrontal cortex, nucleus accumbens da yanki ventral tegmental: karatu ta RT-PCR kuma a cikin dabarun maganin rigakafi. Neuropeptides. 2007; 41 (6): 421 – 431. [PubMed]
  • MacDonald AF, Billington CJ, Levine AS. Tasirin opioid antagonist naltrexone akan ciyar da DAMGO ke haifar dashi a cikin ventral tegmental yankin kuma a cikin kwatancen tsakiya yana ɓoye yankin kwasfa a cikin bera. Am J Physiol Regul Integr Comp Physiol. 2003; 285 (5): R999 – R1004. [PubMed]
  • Mansour A, Fox CA, Akil H, Watson SJ. Maganar opioid-mai karɓar mRNA a cikin bera CNS: alamun tsinkaye da aiki. Trends Neurosci. 1995; 18 (1): 22 – 29. [PubMed]
  • Mena JD, Sadeghian K, Baldo BA. Induction na hyperphagia da kuma carbohydrate ci ta hanyar mu-opioid mai karɓa mai ƙarfi a cikin yankuna da aka tsara na cortex na gaban. J Neurosci. 2011; 31 (9): 3249 – 3260. [PMC free article] [PubMed]
  • Moran TH, Westerterp-Plantenga M. M rawar da rashi a cikin ɓangarorin kwakwalwar ƙwaƙwalwar jijiyoyin da ke cikin ikon sarrafa abinci. Int J Obes (London) 2012; 36 (5): 625 – 626. [PubMed]
  • Nathan PJ, Bullmore ET. Daga dandano hedonics zuwa motsawar motsa jiki: masu karɓar mu-opioid na tsakiya da halayyar cin abinci. Int J Neuropsychopharmacol. 2009; 12 (7): 995 – 1008. [PubMed]
  • Banza ZZ. mu-Abubuwan adawa da mai karɓa kappa-opioid. Magunguna na zamani 1998; 19 (3): 94 – 98. [PubMed]
  • Paxinos G, Watson C. Braaƙwalwar ataƙwalwar a cikin Core Steaksates. Na biyu edn. Orlando: Labaran Ilimi; 1986.
  • Polivy J, Herman CP. Rage cin abinci da binging. Binciken dalili Am Psychol. 1985; 40 (2): 193 – 201. [PubMed]
  • Sabino V, Cottone P, Blasio A, Iyer MR, Steardo L, Rice KC, Conti B, Koob GF, Zorrilla EP. Kunnawa masu sigma-receptors suna haifar da binge-kamar shan giya a cikin Sardinian mai shaye shaye. Neuropsychopharmacology. 2011; 36 (6): 1207 – 1218. [PMC free article] [PubMed]
  • Sabino V, Cottone P, Steardo L, Schmidhammer H, Zorrilla EP. 14-Methoxymetopon, mai haɓakar ƙoshin mu opioid agonist, biphasically yana shafar ciwan ethanol a cikin berayen Sardinar da aka fi so. Psychopharmacology (Berl) 2007; 192 (4): 537 – 546. [PubMed]
  • Sabino V, Cottone P, Zhao Y, Iyer MR, Steardo L, Jr, Steardo L, Rice KC, Conti B, Koob GF, Zorrilla EP. Mai sigma-receptor antagonist BD-1063 yana rage yawan ethanol da ƙarfafa a cikin dabbobin dabbobi na yawan shan ruwa. Neuropsychopharmacology. 2009; 34 (6): 1482 – 1493. [PMC free article] [PubMed]
  • Sanger DJ, McCarthy PS. Bambancin tasirin morphine akan abinci da shan ruwa a cikin abinci an hana musu bera da kuma ciyar da berayen. Psychopharmacology (Berl) 1980; 72 (1): 103 – 106. [PubMed]
  • Schroeder RL, Weinger MB, Vakassian L, Koob GF. Methylnaloxonium ya bazu daga kwakwalwar bera a hankali fiye da naloxone bayan allurar kai tsaye ta intracerebral. Leturo Neurosci. 1991; 121 (1 – 2): 173 – 177. [PubMed]
  • Stein RI, Kenardy J, Wiseman CV, Dounchis JZ, Arnow BA, Wilfley DE. Menene ke haifar da binge a cikin matsalar cin abinci mai yawa?: Binciken mai yiwuwa na magabata da sakamako. Int J Ci rikici. 2007; 40 (3): 195–203. [PubMed]
  • Taqi MM, Bazov I, Watanabe H, Nyberg F, Yakovleva T, Bakalkin G. Prodynorphin mai gabatarwa SNP wanda ke da alaƙa da barasa ya samar da hanyar da ba za a iya amfani da ita ba a cikin hanyar kwakwalwar dan adam ta AP-1 wanda ke iya yin tasiri ga bayyana asalin kwayoyin halitta a cikin kwakwalwar mutum. Brain Res. 2011; 1385: 18 – 25. [PubMed]
  • Vaccarino FJ, Bloom FE, Koob GF. Adearfin mahaɗar nukiliya yana karɓar masu karɓar ƙwaƙwalwar ƙwayoyin cuta a cikin bera. Psychopharmacology (Berl) 1985; 86 (1 – 2): 37 – 42. [PubMed]
  • Vaccarino FJ, Pettit HO, Bloom FE, Koob GF. Sakamakon tsarin kulawa na intracerebroventricular na methyl naloxonium chloride akan sarrafa kansa na heroin a cikin bera. Pharmacol Biochem Behav. 1985; 23 (3): 495 – 498. [PubMed]
  • Wilfley D, Berkowitz R, Goebel-Fabbri A, Hirst K, Ievers-Landis C, Lipman TH, Marcus M, Ng D, Pham T, Saletky R, Schanuel J, Van Buren D. Binge na cin abinci, yanayi, da ingancin rayuwa. a cikin matasa tare da nau'in ciwon sukari na 2: bayanan tushe daga nazarin yau. Kula da ciwon sukari. 2011; 34 (4): 858 – 860. [PMC free article] [PubMed]
  • Williams KL, Broadbridge CL. Narfin naltrexone don rage sarrafa ethanol a cikin beraye shine mafi girma ga allurar subcutaneous a kan allurar intraperitoneal. Barasa. 2009; 43 (2): 119 – 126. [PMC free article] [PubMed]
  • Woolley JD, Lee BS, Kim B, filayen HL. Abubuwan da suke adawa da tasirin intro-nucleus accumbens mu da kappa opioid agonists akan satiety na musamman. Neuroscience. 2007; 146 (4): 1445 – 1452. [PubMed]
  • Zhang M, Kelley AE. Ingantaccen abinci mai mai mai yawa wanda ya biyo bayan tashin hankalin mu-opioid na tashin hankali: taswirar microinjection da magana ta fos. Neuroscience. 2000; 99 (2): 267 – 277. [PubMed]
  • Ziolkowska B, Stefanski R, Mierzejewski P, Zapart G, Kostowski W, Przewlocki R. Yin rikice-rikice baya ba da gudummawa ga tasirin sarrafa kansa na cocaine a kan prodynorphin da kuma bayyanar tsoka ta proenkephalin a cikin jikewar bera. Brain Res. 2006; 1069 (1): 1 – 9. [PubMed]